Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study
Photochemistry and Photobiology · 2026
DOI: 10.1111/php.70081 ↗At a glance
Klinische Studie in Photochemistry and Photobiology, 2026. Written by Nayha Shetty and 5 co-authors. Institution: The Henry W. Lim, MD, Division of Photobiology and Photomedicine, Department of Dermatology, Henry Ford Health, Detroit, Michigan, USA. Major MEDLINE topics: Plant Extracts, Polypodium, Protoporphyria, Erythropoietic. 15 references. The full text is freely available in PubMed Central.
Abstract (original language)
Erythropoietic protoporphyria (EPP) and X‐linked protoporphyria (XLP) cause severe photosensitivity, resulting in significant quality of life (QoL) impairment. This study aims to evaluate the safety and efficacy of Polypodium leucotomos extract (PLE) as an adjunctive therapy in patients with persistent symptoms despite standard dosing of afamelanotide. In this prospective single‐center cohort study, eight adults with confirmed EPP or XLP and ongoing symptoms despite regular afamelanotide implants every 2 months were enrolled. Participants received 480 mg oral PLE daily for 4 months. QoL and symptom severity were measured using questionnaires at baseline, Day 60, and Day 120. Six participants completed the study. Statistically significant improvements in QoL were observed on Day 60 ( p = 0.014), but not at Day 120 ( p = 0.152). Half of participants reported reduced reaction severity. No adverse events occurred. Adjunctive PLE improved short‐term QoL in participants with incomplete symptom control on afamelanotide alone and was well tolerated. Larger studies are warranted.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- The Henry W. Lim, MD, Division of Photobiology and Photomedicine, Department of Dermatology, Henry Ford Health, Detroit, Michigan, USA.
- Health Education Services/Lake Granbury Medical Center Dermatology Residency Program, Dallas, Texas, USA.
- Department of Public Health Science, Henry Ford Health, Detroit, Michigan, USA.
- Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, MI, USA.
ORCID profiles: Rebecca L Quiñonez, Henry W Lim
Cite
APA
Shetty, N., Quiñonez, R. L., Ceresnie, M. S., Ghosh, S., Lim, H. W., & Mohammad, T. F. (2026). Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study. Photochemistry and Photobiology. https://doi.org/10.1111/php.70081
Vancouver
Shetty N, Quiñonez RL, Ceresnie MS, Ghosh S, Lim HW, Mohammad TF. Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study. Photochemistry and Photobiology. 2026. doi:10.1111/php.70081
BibTeX
@article{Shetty2026,
author = {Shetty, Nayha and Quiñonez, Rebecca L and Ceresnie, Marissa S and Ghosh, Sunita and Lim, Henry W and Mohammad, Tasneem F},
title = {Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study},
journal = {Photochemistry and Photobiology},
year = {2026},
doi = {10.1111/php.70081}
}
EUVIMED